Long COVID in cancer patients: preponderance of symptoms in majority of patients over long time period
Background: An increasing number of observational studies have reported the persistence of symptoms following recovery from acute COVID-19 disease in non-cancer patients. The long-term consequences of COVID-19 are not fully understood particularly in the cancer patient population. The purpose of thi...
Main Authors: | Hiba Dagher, Anne-Marie Chaftari, Ishwaria M Subbiah, Alexandre E Malek, Ying Jiang, Peter Lamie, Bruno Granwehr, Teny John, Eduardo Yepez, Jovan Borjan, Cielito Reyes-Gibby, Mary Flores, Fareed Khawaja, Mala Pande, Noman Ali, Raniv Rojo, Daniel D Karp, Patrick Chaftari, Ray Hachem, Issam I Raad |
---|---|
Format: | Article |
Language: | English |
Published: |
eLife Sciences Publications Ltd
2023-02-01
|
Series: | eLife |
Subjects: | |
Online Access: | https://elifesciences.org/articles/81182 |
Similar Items
-
Procalcitonin for antimicrobial stewardship among cancer patients admitted with COVID-19
by: Hiba Dagher, et al.
Published: (2022-12-01) -
Comparing Molnupiravir to Nirmatrelvir/Ritonavir (Paxlovid) in the Treatment of Mild-to-Moderate COVID-19 in Immunocompromised Cancer Patients
by: Andrea J. Haddad, et al.
Published: (2024-03-01) -
International multicenter study comparing COVID-19 in patients with cancer to patients without cancer: Impact of risk factors and treatment modalities on survivorship
by: Issam I Raad, et al.
Published: (2023-01-01) -
Immunological survey of COVID-19 among medicos of tribal preponderant state of India
by: Sushma Kumari, et al.
Published: (2023-01-01) -
Real-World Use of Isavuconazole as Primary Therapy for Invasive Fungal Infections in High-Risk Patients with Hematologic Malignancy or Stem Cell Transplant
by: Hiba Dagher, et al.
Published: (2022-01-01)